"Hospital Duran i Reynals es un complejo que alberga Hestia Duran i Reynals y el ICO. Hestia Duran i Reynals es un centro gestionado por Hestia Alliance que ofrece una prestación integral de servicios sanitarios y sociales gracias a unas completas instalaciones con 428 camas y profesionales orientados a garantizar el máximo bienestar clínico, psicológico y social al paciente mediante una atención individualizada y teniendo en cuenta su grado de dependencia. Presta servicios de atención sociosanitaria (larga estancia, convalecencia y cuidados paliativos) y de salud mental, en régimen de hospitalización u Hospital de Día. Por su parte, el ICO, dependiente del CatSalut, trabaja para reducir el impacto del cáncer en Cataluña."

During the past decade, Hestia Duran I Reynals conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hestia Duran I Reynals" #1 collaborator was "Syntax for Science, S.L" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hestia Duran I Reynals" are "Metastatic Hormone-sensitive Prostate Cancer" (1 trials) and "Resectable Pancreatic Ductal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Hestia Duran I Reynals" in a lesser frequency.

Most popular intervention types in "Hestia Duran I Reynals" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ADT (androgen deprivation therapy)" (1 trials), "Docetaxel" (1 trials), "Ipilimumab 5 MG/ML" (1 trials), "NALRINOX combination" (1 trials) and "Nivolumab 10 MG/ML" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hestia Duran I Reynals" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hestia Duran I Reynals". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hestia Duran I Reynals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hestia Duran I Reynals, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".